UJI DAYA HAMBAT EKSTRAK DAUN KETAPANG (TERMINALIA CATAPPA L.) TERHADAP CANDIDA ALBICANS
PHARMACON · 2025
DOI: 10.35799/bqkqfx82 ↗Kurz gefasst
Fachartikel in der Zeitschrift PHARMACON, 2025. Verfasst von Ineke Tumbel und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This research aims to determine the inhibition of ketapang leaf extract (Terminalia catappa L.) against Candida albicans on the acrylic base of removable orthodontic appliances. Pure experimental method in the form of laboratory tests with post test control group design. The test method is a well to see the fungal growth response. Samples were divided into 4 groups each given a concentration of 40%, 60%, 80%, 100%, positive control chlorhexidine gluconate 0.2%, and negative control distilled water. Testing was carried out at the Laboratory of Pharmaceutical Microbiology FMIPA UNSRAT. Normality test results showed p>0.05 which means the data is normally distributed. One Way Anova test showed p
Zitieren
APA
Tumbel, I., Anindita, P., & Kawengian, S. (2025). UJI DAYA HAMBAT EKSTRAK DAUN KETAPANG (TERMINALIA CATAPPA L.) TERHADAP CANDIDA ALBICANS. PHARMACON. https://doi.org/10.35799/bqkqfx82
Vancouver
Tumbel I, Anindita P, Kawengian S. UJI DAYA HAMBAT EKSTRAK DAUN KETAPANG (TERMINALIA CATAPPA L.) TERHADAP CANDIDA ALBICANS. PHARMACON. 2025. doi:10.35799/bqkqfx82
BibTeX
@article{Tumbel2025,
author = {Tumbel, Ineke and Anindita, Pritartha and Kawengian, Shirley},
title = {UJI DAYA HAMBAT EKSTRAK DAUN KETAPANG (TERMINALIA CATAPPA L.) TERHADAP CANDIDA ALBICANS},
journal = {PHARMACON},
year = {2025},
doi = {10.35799/bqkqfx82}
}
EUVIMED